Effect of CMV serology on outcome after clinical intestinal transplantation.
Furukawa
H
H
Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania, USA.
Kusne
S
S
Abu-Elmagd
K
K
Green
M
M
Reyes
J
J
Starzl
T E
TE
Todo
S
S
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D003586:Cytomegalovirus Infections / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control; D015774:Ganciclovir / Q000627:therapeutic use; D006085:Graft Survival; D006801:Humans; D015994:Incidence; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation*; D016031:Liver Transplantation; D011183:Postoperative Complications; D012189:Retrospective Studies; D015996:Survival Rate; D014184:Transplantation, Homologous / Q000401:mortality / Q000473:pathology; D016896:Treatment Outcome
D000998:Antiviral Agents; D015774:Ganciclovir